delayed treatments, propagation of drug-resistant TB, increased hospitalizations, increased cost of drugs, and increased mortality). These data should help make the development of effective TB information supply chains a priority along with the development of new therapeutics, new diagnostics, improved infection control practices, and other critical components of an effective TB control program.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement